Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-156690
Filing Date
2016-12-23
Accepted
2016-12-23 17:11:16
Documents
1
Period of Report
2016-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 20695
  Complete submission text file 0001209191-16-156690.txt   22081
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

EIN.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Williams Lewis T (Reporting) CIK: 0001475714 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36070 | Film No.: 162069379